These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18823878)

  • 41. Lesions of the nucleus basalis magnocellularis do not impair prepulse inhibition and latent inhibition of fear-potentiated startle in the rat.
    Schauz C; Koch M
    Brain Res; 1999 Jan; 815(1):98-105. PubMed ID: 9974127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excitotoxic lesions of the medial amygdala attenuate olfactory fear-potentiated startle and conditioned freezing behavior.
    Cousens GA; Kearns A; Laterza F; Tundidor J
    Behav Brain Res; 2012 Apr; 229(2):427-32. PubMed ID: 22249137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm.
    Missig G; Ayers LW; Schulkin J; Rosen JB
    Neuropsychopharmacology; 2010 Dec; 35(13):2607-16. PubMed ID: 20844476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural substrates of individual differences in human fear learning: evidence from concurrent fMRI, fear-potentiated startle, and US-expectancy data.
    van Well S; Visser RM; Scholte HS; Kindt M
    Cogn Affect Behav Neurosci; 2012 Sep; 12(3):499-512. PubMed ID: 22451349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acoustic startle and fear-potentiated startle in rats selectively bred for fast and slow kindling rates: relation to monoamine activity.
    Anisman H; Kelly O; Hayley S; Borowski T; Merali Z; McIntyre DC
    Eur J Neurosci; 2000 Dec; 12(12):4405-16. PubMed ID: 11122351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variation in brain-derived neurotrophic factor and human fear conditioning.
    Hajcak G; Castille C; Olvet DM; Dunning JP; Roohi J; Hatchwell E
    Genes Brain Behav; 2009 Feb; 8(1):80-5. PubMed ID: 19220486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle.
    Greba Q; Gifkins A; Kokkinidis L
    Brain Res; 2001 Apr; 899(1-2):218-26. PubMed ID: 11311883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AX+/BX- discrimination learning in the fear-potentiated startle paradigm in monkeys.
    Winslow JT; Noble PL; Davis M
    Learn Mem; 2008 Feb; 15(2):63-6. PubMed ID: 18230674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporal characteristics of enhancement of startle by stimulation of the amygdala.
    Rosen JB; Davis M
    Physiol Behav; 1988; 44(1):117-23. PubMed ID: 2853376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lesions of the central nucleus of the amygdala block the excitatory effects of septal ablation on the acoustic startle reflex.
    Melia KR; Sananes CB; Davis M
    Physiol Behav; 1992 Jan; 51(1):175-80. PubMed ID: 1741445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acoustic startle and fear-potentiated startle in alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
    Mckinzie DL; Sajdyk TJ; Mcbride WJ; Murphy JM; Lumeng L; Li TK; Shekhar A
    Pharmacol Biochem Behav; 2000 Apr; 65(4):691-6. PubMed ID: 10764924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posttraining lesion of the superior colliculus interferes with feature-negative discrimination of fear-potentiated startle.
    Waddell J; Heldt S; Falls WA
    Behav Brain Res; 2003 Jun; 142(1-2):115-24. PubMed ID: 12798272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle.
    Walker DL; Cassella JV; Lee Y; De Lima TC; Davis M
    Neurosci Biobehav Rev; 1997 Nov; 21(6):743-53. PubMed ID: 9415899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone.
    Winslow JT; Noble PL; Davis M
    Biol Psychiatry; 2007 Feb; 61(3):389-95. PubMed ID: 16730332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.
    Lee Y; Davis M
    J Neurosci; 1997 Aug; 17(16):6434-46. PubMed ID: 9236251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
    Campeau S; Miserendino MJ; Davis M
    Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration.
    Ayers LW; Missig G; Schulkin J; Rosen JB
    Neuropsychopharmacology; 2011 Nov; 36(12):2488-97. PubMed ID: 21796104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amygdala efferents mediating electrically evoked startle-like responses and fear potentiation of acoustic startle.
    Yeomans JS; Pollard BA
    Behav Neurosci; 1993 Aug; 107(4):596-610. PubMed ID: 8397864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological and anatomical analysis of fear conditioning.
    Davis M
    NIDA Res Monogr; 1990; 97():126-62. PubMed ID: 2247135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visual cortex ablations do not prevent extinction of fear-potentiated startle using a visual conditioned stimulus.
    Falls WA; Davis M
    Behav Neural Biol; 1993 Nov; 60(3):259-70. PubMed ID: 8297322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.